medmix AG (SWX:MEDX)
Switzerland · Delayed Price · Currency is CHF 8.84
+0.25 (2.91%)
Jul 31, 2026, 5:30 PM CET
medmix AG Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 437 | 448 | 483.9 | 486.6 | 477.1 | 457.3 | |
Revenue Growth | -2.46% | -7.42% | -0.56% | 1.99% | 4.33% | 30.17% |
Cost of Revenue | 276.5 | 286.1 | 324.2 | 328.9 | 301.7 | 276.1 |
Gross Profit | 160.5 | 161.9 | 159.7 | 157.6 | 175.4 | 181.2 |
Selling, General & Admin | 112.5 | 114.9 | 116.4 | 119 | 103 | 95.6 |
Research & Development | 20.6 | 19.6 | 25.4 | 25.7 | 23.6 | 23 |
Other Operating Expenses | 9.8 | 4.5 | 5 | -3.1 | 29.3 | 2.7 |
Total Operating Expenses | 142.9 | 139 | 146.8 | 141.6 | 155.9 | 121.3 |
Operating Income | 17.7 | 22.8 | 12.9 | 16 | 19.6 | 59.9 |
Interest Income | 1.4 | 1.3 | 1.1 | 1.3 | 0.7 | 0 |
Interest Expense | -13.8 | -10.7 | -12.1 | -10 | -6.5 | -8.1 |
Other Non-Operating Income (Expense) | -3.8 | -4.5 | -8.3 | -4.4 | -1.6 | -0.5 |
Total Non-Operating Income (Expense) | -16.2 | -13.9 | -19.3 | -13.1 | -7.4 | -8.6 |
Pretax Income | 1.4 | 9 | -6.3 | 2.9 | 12.2 | 51.3 |
Provision for Income Taxes | 0.5 | 1.9 | 0 | 2.2 | 0.6 | 7.3 |
Net Income | 0.9 | 7 | -6.4 | 0.7 | 11.6 | 44 |
Minority Interest in Earnings | 0.8 | 0.6 | 1 | 0.4 | - | - |
Net Income to Common | 0.1 | 6.4 | -7.4 | 0.3 | 11.6 | 44 |
Net Income Growth | -98.44% | - | - | -97.41% | -73.64% | 358.33% |
Shares Outstanding (Basic) | 41 | 41 | 41 | 41 | 41 | 41 |
Shares Outstanding (Diluted) | 41 | 42 | 41 | 41 | 41 | 41 |
Shares Change | -1.94% | 0.24% | 0.50% | 0.25% | -0.15% | 20.14% |
EPS (Basic) | - | 0.16 | -0.18 | 0.01 | 0.28 | 1.07 |
EPS (Diluted) | - | 0.15 | -0.18 | 0.01 | 0.28 | 1.07 |
EPS Growth | - | - | - | -96.43% | -73.83% | 282.14% |
Free Cash Flow | 31.7 | 33.3 | 48.1 | 9.7 | 11.2 | 57.5 |
Free Cash Flow Growth | -4.81% | -30.77% | 395.88% | -13.39% | -80.52% | 576.47% |
Free Cash Flow Per Share | 0.78 | 0.80 | 1.16 | 0.24 | 0.27 | 1.40 |
Dividends Per Share | 0.100 | 0.100 | 0.500 | 0.500 | 0.500 | 0.500 |
Dividend Growth | 0% | -80.00% | 0% | 0% | 0% | - |
Gross Margin | 36.73% | 36.14% | 33.00% | 32.39% | 36.76% | 39.62% |
Operating Margin | 4.05% | 5.09% | 2.67% | 3.29% | 4.11% | 13.10% |
Profit Margin | 0.21% | 1.56% | -1.32% | 0.14% | 2.43% | 9.62% |
FCF Margin | 7.25% | 7.43% | 9.94% | 1.99% | 2.35% | 12.57% |
EBITDA | 74.5 | 78.3 | 74.5 | 74.4 | 70.7 | 111.6 |
EBITDA Margin | 17.05% | 17.48% | 15.40% | 15.29% | 14.82% | 24.40% |
EBIT | 17.7 | 22.8 | 12.9 | 16 | 19.6 | 59.9 |
EBIT Margin | 4.05% | 5.09% | 2.67% | 3.29% | 4.11% | 13.10% |
Effective Tax Rate | 35.71% | 21.11% | 0.00% | 75.86% | 4.92% | 14.23% |